e-learning
resources
Milan 2017
Sunday, 10.09.2017
Extrapulmonary comorbidities in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use of heart failure medications in outpatients with COPD and congestive heart failure: a Danish nationwide cohort study
D. Rasmussen (Glumsø, Denmark)
Source:
International Congress 2017 – Extrapulmonary comorbidities in COPD
Session:
Extrapulmonary comorbidities in COPD
Session type:
Thematic Poster
Number:
688
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Rasmussen (Glumsø, Denmark). Use of heart failure medications in outpatients with COPD and congestive heart failure: a Danish nationwide cohort study. 688
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Carvedilol, bisoprolol, and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary disease: A nationwide population-based study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
COPD in heart failure patients
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Prevalence and characteristics of congestive heart failure in elderly patients with chronic lung disease
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Prevalence of Cheyne-Stokes respiration in congestive heart failure patients with modern medical treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 113s
Year: 2004
The characterization of diastolic function of the right ventricle in patients with COPD combined with congestive heart failure (CHF)
Source: International Congress 2014 – Predictors
Year: 2014
COPD prevalence in chronic heart failure
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Myocardial infarction, heart failure and mortality in patients with COPD in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study.
Source: International Congress 2019 – More and more COPD
Year: 2019
Testing a measurement model of dyspnoea in adults hospitalized for heart failure
Source: Annual Congress 2008 - Nursing interventions in the management of COPD and dyspnoea
Year: 2008
Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study.
Source: International Congress 2019 – More and more COPD
Year: 2019
Effect of acute beta-blocker withholding on the ventilatory efficiency in patients with advanced chronic congestive heart failure
Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans
Year: 2009
Admission due to heart failure and pulmonary function testing: is there a COPD?
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Predictors of failure of non-invasive ventilation in patients with respiratory failure; a prospective study
Source: Annual Congress 2012 - Application of noninvasive ventilation in non-obstructive patients
Year: 2012
COPD and co-existent chronic heart failure (CHF): Response to pulmonary rehabilitation (PR)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016
Acute hemodynamic effects of non-invasive ventilation (NIV) in patients with exacerbation of congestive heart failure (CHF)
Source: Eur Respir J 2005; 26: Suppl. 49, 550s
Year: 2005
Incorporating patients with chronic heart failure (CHF) into pulmonary rehabilitation (PR): a propensity matched analysis
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Efficacy of BiPAP AutoSV advanced in subjects with congestive heart failure and central apnea
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Respiratory drive and exercise capacity in congestive heart failure patients
Source: Eur Respir J 2004; 24: Suppl. 48, 217s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept